Exhibit 10.2
EX-10.2 8-K · CIK 1326205 · 0001185185-26-002410
EXHIBIT 10.2
View original filing on SEC EDGAR → · seen Jun 08, 2026, 23:52 EDT
FILING DETAILS
- Filer
- IGC Pharma, Inc.
- Period of report
- Jun 05, 2026
- Filed
- Jun 08, 2026
- SEC file no.
- 001-32830
- State of inc.
- MD
- SIC
- 2834
- Location
- POTOMAC, MD
- Entry into a Material Definitive Agreement
- Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
- Financial Statements and Exhibits